U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. FDA-NRC Workshop: Targeted Alpha Emitting Radiopharmaceuticals, with Focus on Ac-225 - 09/22/2021 - 09/22/2021
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
FDA-NRC Workshop: Targeted Alpha Emitting Radiopharmaceuticals, with Focus on Ac-225
September 22, 2021

Date:
September 22, 2021

ABOUT THE PUBLIC WORKSHOP

The virtual public workshop will be held Wednesday, September 22, 2021, from 9:00 a.m. – 4:30 p.m. EDT. Discussions will include: Targeted Alpha Emitters with Focus on Actinium-225 Radiotherapies; Novel Radiopharmaceuticals: Standards Development, Product Quality, Supply and Demand; Clinical Considerations for Development of Novel Radiopharmaceuticals; User and Industry Perspectives.

REGISTRATION

The workshop will be conducted using Cisco WebEx. To participate in the WebEx workshop, please register by September 10, 2021 using the following event address: https://usnrc.webex.com/usnrc/onstage/g.php?MTID=ed88ca555fe84a004cc98c4e75ada3d40

MEETING MATERIALS

Agenda (PDF - 157 KB)
Presenter Biographies (PDF - 389 KB)

ONLINE ATTENDANCE (WEBCAST)

This meeting will be broadcast live on the NRC’s Webcast portal at https://video.nrc.gov/. (Please note that the NRC’s Webcast portal will allow you to watch a live broadcast of the workshop. To ask panel discussion questions via chat or audio you must register for and attend the WebEx meeting.)

SPECIAL ACCOMMODATIONS

The Webcast (https://video.nrc.gov/) will be closed captioned.

REQUESTS FOR PUBLIC COMMENTS OR QUESTIONS

If you would like to submit questions to be considered by the workshop hosts and presenters, please submit them, any time before the event date, via email to ONDPublicMTGSupport@fda.hhs.gov.

CONTACT

For additional details, contact

Technical Contacts:
Frank Lutterodt, Project Manager, DIRM,
FDA Frank.Lutterodt@fda.hhs.gov

Lisa Dimmick, Team Leader, Medical Radiation Safety,
U.S.NRC Lisa.Dimmick@nrc.gov

Meeting Logistics: Sarah Lopas Sarah.Lopas@nrc.gov

Event Materials

Title File Type/Size
Session IV Presentations pdf (5.26 MB)
Session III Presentations pdf (5.68 MB)
Session II Presentations pdf (11.53 MB)
Session I Presentations pdf (3.87 MB)
Back to Top